Journal of Controlled Release 2024
14 papers
The 2024 volume of the Journal of Controlled Release highlights advancements in stimuli-responsive drug delivery systems and multi-functional biomaterials. Research themes focus heavily on oncology, with studies investigating pH and glutathione-responsive nano-herb delivery for colorectal cancer and reactive oxygen species-responsive hydrogels for chemoimmunotherapy. Other significant work explores metabolic targeting, such as using nanodiamonds to impair tumor glycolysis, and synergistic treatments for non-small cell lung cancer through dual-inhibitor co-assemblies.
Beyond oncology, the journal features research on regenerative medicine and inflammatory conditions. Notable examples include hydrogel-bioactive glass dressings designed to enhance neurogenesis in infected wounds and Janus nanocomposites for periodontitis therapy. Prolific contributors for the year include authors such as Biao Dong, Chunyan Li, and Jong Seung Kim. These publications emphasize the development of coordinative modular assemblies and spatiotemporal delivery mechanisms to improve therapeutic precision. The 2024 edition reflects a trend toward integrating nanotechnology with immunotherapy to address complex pathological environments.